Discover 1,132 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,132
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: New Haven CT, The Bronx NY, Laurelton NY, New York NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase3, Recruiting
Active & Responsive
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
for
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV,
Location: Norwalk CT
Sponsor: Nuvance Health
Sex: All
Age: 18+
Code: NCT04406831
Recruiting
Active & Responsive
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
for
Pancreatic Neoplasms
Location: Norwalk CT
Sponsor: Nuvance Health
Sex: All
Age: 50 - 70+
Code: NCT03250078
Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Norwalk CT, Manhasset NY, Hempstead NY, New York NY,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
for
Moderate to Severe Glabellar Lines
Location: Westport CT, Mount Kisco NY, New York NY, Latham NY,
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT07435428
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: Stamford CT, Port Jefferson Station NY, New Haven CT,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
for
Episodic Migraine
Location: Stamford CT, Port Jefferson Station NY, New Haven CT,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018700
Phase3, Recruiting
Active & Responsive
Study of EVO756 in Adults With Migraine
for
Migraine
Location: Stamford CT, Toms River NJ, Westborough MA, Amherst NY,
Sponsor: Evommune, Inc.
Sex: All
Age: 18 - 64
Code: NCT07616128
Phase2, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Stamford CT, New Bedford MA, Needham MA, Rochester NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase2, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Stamford CT, New Bedford MA, Needham MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase2, Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Stamford CT, New York NY, Newark NJ, Poughkeepsie NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Stamford CT, Bridgeport CT, Hamden CT, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Stamford CT, The Bronx NY, Summit NJ, Hinsdale IL,